The effectiveness of smoking cessation treatments used in the "real world"

Similar documents
Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking

"Real-world" effectiveness of smoking cessation treatments: a population study

Trends in electronic cigarette use in England

Smoking and Smoking Cessation in England 2011: Findings from the Smoking Toolkit Study

Smoking cessation: the value of working together. Dr Donita Baird and Dr Sarah L White

Smoking cessation interventions and services

Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence

HOW COST-EFFECTIVE IS NO SMOKING DAY?

Primary Care Smoking Cessation. GP and Clinical Director WRPHO Primary Care Advisor MOH Tobacco Team Target Champion Primary Care Tobacco

REGIONAL PHARMACY SPECIALIST SMOKING CESSATION SERVICE FEBRUARY A Pharmacist s Guide

Smoking cessation interventions and services

Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks?

BASIC SKILLS FOR WORKING WITH SMOKERS

Associations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study

BASIC SKILLS FOR WORKING WITH SMOKERS

Best practice for brief tobacco cessation interventions. Hayden McRobbie The Dragon Institute for Innovation

Effective Treatments for Tobacco Dependence

System change interventions for smoking cessation

Smoking Cessation. Hassan Sajjad Pulmonary & Critical Care

Presentation outline

Best Practices in Tobacco Treatment IDN

Does cigarette reduction while using nicotine replacement predict quitting? Observational evidence from the Rapid Reduction Trial

Helping People Quit Tobacco

A Systematic Review of the Efficacy and Clinical Effectiveness of Group Analysis and Analytic/Dynamic Group Psychotherapy

Tobacco dependence: Implications for service provision

Background. Abstinence rates associated with varenicline

Pharmacotherapy for Tobacco Dependence Treatment

Brief Intervention for Smoking Cessation in Substance Use Treatment By Carol Daws

Cost-effectiveness of brief intervention and referral for smoking cessation

Potential Costs and Benefits of Smoking Cessation for New Jersey

Sample Managed Care Organization Survey Questions to Assess Smoking Prevalence and Available Cessation Benefits

Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D.

Comparing the Cochrane review of electronic cigarettes to other meta-analyses

Local Stop Smoking Services: service delivery and monitoring guidance 2011/12 Key point summary

3. Chantix [package insert]. New York, NY: Pfizer, Inc,; Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine

Smoking Cessation: Where Are We Now? Nancy Rigotti, MD

Evidence-based Practice

Smoking Cessation: Good News at Last!

Brief Intervention for Smoking Cessation. National Training Programme

The 5A's are practice guidelines on tobacco use prevention and cessation treatment (4):

The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in Englandadd_

Health Promotion Service Project Overview

Identifying effective behaviour change techniques in brief interventions to reduce alcohol consumption. Susan Michie

Randomized controlled trial of physical activity counseling as an aid to smoking cessation: 12 month follow-up

E-CIGARETTES CANCER INSIGHT WHAT YOU NEED TO KNOW ABOUT FOR PRACTICE NURSES. INSIDE: A3 poster to display in your practice.

Month/Year of Review: March 2014 Date of Last Review: April 2012

Importance of smoking cessation in improving the physical and mental health of people with mental illness

Tobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing

SMOKING CESSATION IS HARD

Text 1: E-Cigarettes, the solution or another risk factor?

E-CIGARETTES CANCER INSIGHT WHAT YOU NEED TO KNOW ABOUT. FOR GPs. INSIDE: A3 poster to display in your practice. October Created by Freepik

Smoking Counselling and Cessation Service in Hospital Authority 7 May HA Convention 2014

The Cochrane Database of Systematic Reviews The Cochrane Library, Copyright 2005, The Cochrane Collaboration Volume (1) 2005 [no page #]

Pharmacological interventions for smoking cessation: an overview and network meta-analysis (Review)

Smoking cessation services

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

Preventing ill health -

Tobacco Treatment Measures KATHY WONDERLY RN, MSED, CPHQ CONSULTANT DEVELOPED: JANUARY 2018

Smokefree mums and bubs

Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study

Cardiovascular disease and varenicline (Champix)

Quitting smoking is hard

Varenicline Update. Serena Tonstad, MD, PhD Dept of Preventive Cardiology Ullevål University Hospital Oslo, Norway

Health systems challenges for tobacco dependence treatment in LMICs: Smokeless tobacco and Bidi

Effect of real-time monitoring and notification

Factors associated with differences in quit rates between 'specialist' and 'community' stop-smoking practitioners in the English Stop-Smoking Services

Tobacco Use Dependence and Approaches to Treatment

Electronic cigarettes for smoking cessation

Healthcare financing systems for increasing the use of tobacco dependence treatment (Review)

OXLEAS NHS FOUNDATION TRUST RESEARCH PROPOSAL

5. Offer pharmacotherapy to all smokers who are attempting to quit, unless contraindicated.

Yorkshire & Humber Respiratory Programme Report

Number of records submitted: 14,750 Number of participants: Part 1 = 146 hospitals (120 trusts); Part 2 = 140 hospitals (119 trusts)

This standard is not designed to be prescriptive of how, when or in what format training is delivered although, some guidelines are included.

Supporting smokers with mental health problems

Smoking Cessation Pharmacotherapy Guidelines

Article Electronic Cigarette Use and Smoking Abstinence in Japan: A Cross-Sectional Study of Quitting Methods

Smoking Cessation Profile: Betsi Cadwaladr University Health Board 2012/2013

Smoking Cessation Pilot Program

Performance Measure Name: TOB-3 Tobacco Use Treatment Provided or Offered at Discharge TOB-3a Tobacco Use Treatment at Discharge

Title: Varenicline for Smoking Cessation. Date: June 4, Context and policy issues:

You Can Make a Difference!

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax

PHARMACOTHERAPY OF SMOKING CESSATION

Population-Based Smoking Cessation Strategies

Outpatient Tobacco Addiction Treatment Pathway Additional Notes

Yorkshire & Humber Respiratory Programme Report

Quitting is all about finding what works for you.

Nicotine Replacement Therapy, Zyban and Champix. Name of presentation

Drug Use Evaluation: Smoking Cessation

Pharmacotherapy Safety and Efficacy in Adolescent Smoking Cessation

Nicotine & Tobacco Research Advance Access published July 7, Differences in longer-term smoking abstinence after

Yorkshire & Humber Respiratory Programme Report

PROTOCOLS AND PRISMA DIAGRAMS

How best to get your patients to stop smoking. Dr Alex Bobak GP and GPSI in Smoking Cessation Wandsworth, London

Guideline scope Smoking cessation interventions and services

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018

Response to Scottish Government A Consultation on Electronic Cigarettes and Strengthening Tobacco Control in Scotland December 2014

Evidence base, treatment policy and coverage in England. Ann McNeill

Transcription:

Medizinische Fakultät The effectiveness of smoking cessation treatments used in the "real world" Daniel Kotz, PhD 11 March 2015 Heinrich-Heine-University Düsseldorf Maastricht University University College London University of Edinburgh www.daniel-kotz.de

Background study two forms of smoking cessation treatment 1. behavioral support 2. medication evidence for effectiveness from multiple RCTs high internal validity low external validity (do not reflect the "real world") Medizinische Fakultät

Medizinische Fakultät

Background study previous observational studies few studies, inconsistent results methodological limitations small sample size no representative sampling of population unclear definition / incomplete description of treatment methods (medication, behavioural support) inadequate control for confounding (nicotine dependence) Medizinische Fakultät

Background study aim: estimate "real world" effectiveness of common smoking cessation treatments using data from the English "Smoking Toolkit Study" Medizinische Fakultät

monthly national representative sample N~1,800 face-to-face survey

Methods N = 1,560 (Nov 2006 March 2012) Baseline interview 6 month questionnaire (Response 21%) Smoker Quit attempt

Methods Baseline interview 1: Medication on prescription + specialist behavioral support 2: Medication on prescription + brief advice 3: NRT bought over-thecounter 4: None of the above (reference) 6 month questionnaire Non-smoker (yes/no) Medication on prescription (method 1, 2): NRT, varenicline, or bupropion Specialist behavioral support (method 1): 1-to-1 or group behavioral support by a National Health Service Stop Smoking Service Brief advice (method 2): advice delivered by the prescribing health care professional

Methods Baseline interview 1: Medication on prescription + specialist behavioral support 2: Medication on prescription + brief advice 3: NRT bought over-thecounter 6 month questionnaire dependence (urges) social grade age sex time since attempt started no. of previous attempts abrupt vs. cutting down first 4: None of the above (reference) Method used during quit attempt (1, 2, 3, or 4) Confounder Non-smoker (yes/no)

Baseline characteristics

Main findings Users / method: 4.8% (N=75) 20.8% (N=324) 29.9% (N=467) 44.5% (N=694) 1: Medication on prescription + specialist behavioral support 2: Medication on prescription + brief advice 3: NRT bought over-thecounter 4: None of the above (reference) aor=2.58 (95%CI=1.48-4.52) aor=1.55 (95%CI=1.11-2.16) aor=0.68 (95%CI=0.49-0.94) (reference)

Discussion our findings compared with RCTs two effect estimates for medication on prescription with specialist behavioural support (OR=2.58) or brief advice (OR=1.55) similar to meta-analyses 1-3 estimate for NRT over-the-counter (OR=0.68) conflicts with meta-analysis (OR=2.5) 4 inappropriate usage an low adherence? 1 Stead (Cochrane 2012); 2 Hughes (Cochrane 2011); 3 Cahill (Cochrane 2012) 4 Hughes (Tob Control 2003) Medizinische Fakultät

Discussion RCTs on NRT over-the-counter cannot mimic "real life" e.g., largest RCT acknowledges that "complete reproducibility of the over-the-counter setting was impossible" 1 participants were asked to set a quit date within 7 days they were given instructions on how to use the medication the first use was under supervision adverse events were monitored adherence was maintained during several site visits 1 Davidson (Arch Fam Med 1998) Medizinische Fakultät

Limitations low response to 6-month follow-up (21%), but no indication for biased relative effectiveness potential residual confounding (e.g. co-morbidity, psychological distress) outcome (non-smoking) not biochemically validated no data on actual use of, adherence to, medication and support Medizinische Fakultät

Strengths first study comparing prescription medication when offered with/without specialist behavioral support representative sample of English population sufficient power to detect effect of specialist behavioral support despite low prevalence monthly aggregated data over a 5-year period reduces potential seasonal bias Medizinische Fakultät

Conclusion In the "real world"... combination of specialist behavioral support + medication on prescription most successful medication on prescription + brief advice also effective more smokers should be guided into these forms of treatment Medizinische Fakultät

Conclusion In the "real world"... NRT bought over-the-counter may be associated with reduced success rate research needed on underlying causes and consequences Medizinische Fakultät

Medizinische Fakultät

Medizinische Fakultät